Cristiane D. Bergerot/X
May 2, 2025, 11:11
Cristiane Bergerot: FKSI-23 Measure for RCC is Available on the FACIT Website
Cristiane Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared a post on X:
“Excited that our FKSI-23 measure, designed to assess HRQOL in patients with localized and advanced RCC, is available on the FACIT website.”
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared this post, adding:
“Congrats, Cristiane Bergerot, on leading the way with HRQIL relevant in the current therapeutic era in Kidney cancer! Congrats to mentors Sumanta Pal and Tom Powles.”
More posts featuring Cristiane Bergerot and Shilpa Gupta.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 2, 2025, 11:09
May 2, 2025, 10:31
May 2, 2025, 10:21
May 2, 2025, 10:19